Talk Bio

Actionable Insights Powered by AI

Subscribe

Galaxies

GSK and iTeos End Belrestotug TIGIT Program After Disappointing Lung Cancer Results

talkbio0Tagged , , , , , , , , , , ,

GSK; iTeos; belrestotug; TIGIT; lung cancer; dostarlimab; clinical trial; drug development; GALAXIES Lung-201; immuno-oncology; progression-free survival

Read More